PTX-400

N/A

Report date: 2025/01/26 19:17:10

Base Information

Drug NamePTX-400
Drug Alias Nameulcerative colitis/Crohn's disease Biological Therapeutic (PanTheryx)PTX-400
ClassificationBiologics
Mechanisms of ActionImmunomodulatorsMicrobiome modulators
TargetsUpdating
Therapy Area/IndicationsCrohn DiseaseColitis, Ulcerative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPanTheryx Inc
China Registration ClassN/A

Develop Information

Active CompaniesPanTheryx Inc
Inactive CompaniesN/A
Active IndicationsCrohn DiseaseColitis, Ulcerative
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A